Business Practice

From video games to climate change; looking back on a handful of articles from 2022.

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Two drugs, two different destinies. Does their story prove that business practice makes the difference?

Pharma depends on academia, but that relationship can become better… and more fluid

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

Water is the giver of life, but could it be a giver of untold medicines too?

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?